Knauer Joins Industrial Sustainability Research Project
Knauer Wissenschaftliche Geräte GmbH has joined the European Union Funded IMPRESS research programme, whose goal is to advance the sustainable production of raw chemistry materials.
From September 2019, Knauer Wissenschaftliche Geräte GmbH (Berlin, Germany) has joined the European Union Funded IMPRESS research programme, whose goal is to advance the sustainable production of raw chemistry materials.
The research project, whose acronym stands for “Integration of efficient downstreaM PRocessEs for Sugars and Sugar alcohols”, is driven by a consortium of 10 member companies and research institutions receiving a total grant of 13 million euros to date.
Over the course of four years, the IMPRESS team aims to demonstrate a new kind of biorefinery, which allows converting plant-based non-food materials into important base chemicals, for example, the production of monoethylene glycol without fossil source materials. This would allow the sustainable production of in-demand polyesters.
Knauer’s role in the IMPRESS consortium is to contribute with its expertise and liquid chromatography purification technology, including the efficient continuous separation technology simulated moving bed (SMB) chromatography.
Other research areas in the project include:
- Biotechnology to break up the plant material into sugars
- The use of sustainable catalytic process technology for the creation of important base chemicals
- The development of new separation methods to purify intermediates and end products.
For more information, please visit: www.knauer.net
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
